Content area
Full Text
Eye (2017) 31, 668676 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 0950-222X/17
http://www.nature.com/eye
Web End =www.nature.com/eye
Continuing Medical Education:
99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy
B Sun, Z Zhang, C Dong, Y Zhang, C Yan and S Li
Release date: 7 April 2017; Expiration date: 7 April 2018
This activity has been planned and implemented through the joint providership of Medscape, LLC and Springer Nature. Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)t. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certicate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures;(2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at www.medscape.org/journal/eye; (4) view/print certicate.
Learning Objectives
Upon completion of this activity, participants will be able to:
1. Evaluate the typical clinical course of thyroid-associated ophthalmopathy (TAO)
2. Assess the usefulness of octreotide scintigraphy in measuring disease activity in TAO
3. Distinguish the optimal scintigraphy uptake ratio cutoff point to identify active vs inactive TAO
4. Analyze which eye muscle antibodies correlate with disease activity in TAO
Authors/Editors disclosure information
Andrew J Lotery has disclosed the following relevant nancial relationships: served as an advisor or consultant for: Bayer
HealthCare Pharmaceuticals; Roche. Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals.
Bin Sun has disclosed no relevant nancial relationships. Zhaoxia Zhang has disclosed no relevant nancial relationships.
Chao Dong has disclosed no relevant nancial relationships. Yuanming Zhang has disclosed no relevant nancial relationships.
Chunxia Yan has disclosed no relevant nancial relationships. Shengbin Li has disclosed no relevant nancial relationships.
Journal CME author disclosure informationCharles P Vega has disclosed the following relevant nancial relationships: served as an advisor or consultant for: Allergan, Inc.; McNeil Consumer Healthcare. Served as a speaker or...